Marine Secondary Metabolites
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 June 2015) | Viewed by 340506
Special Issue Editor
Interests: isolation and stereostructural elucidation of new leads compounds in anti-inflammatory and anti-cancer drug discovery; exploration of the QQ and the QS system in bacteria symbiotic with sponges with the goal to create novel leads in antibacterial drug discovery; cyanobacteria as source of novel lead compounds and toxins
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This special issue is dedicated to Professor Ernesto Fattorusso, one of the pioneers in Chemistry of Marine Natural Products, who passed away in July 2012.In the last three decades, research on natural products has clearly shown that the chances of finding new bioactive compounds are remarkably higher among the less studied marine organisms than among terrestrial organisms. The biosynthetic capability of marine organisms is amazing, even if the discovery that symbiotic microorganisms are the true producers of many of these compounds provided at least a partial answer. The jointed work of chemists of natural products with pharmacologists gave rise to hundred of publications showing the potentiality of marine natural products as leads in the drug discovery.
This special issue will be focus on recent accomplishments in this field, providing a tool for young researchers that want to approach this terribly interesting world.Dr. Valeria Costantino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Bioactive Compounds from Marine Sponges 2020 in Marine Drugs (6 articles)